ClinicalTrials.Veeva

Menu

Pangenomic Study During Alcoholic Cirrhosis (CDCHC)

N

Nantes University Hospital (NUH)

Status

Completed

Conditions

Alcoholic Cirrhosis

Treatments

Genetic: DNA extraction

Study type

Observational

Funder types

Other

Identifiers

NCT01065233
BRD/07/08-M

Details and patient eligibility

About

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome.

The determining of a genomic mapping of " single nucleotide polymorphisms " (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition.

In this study, the investigators will identify predictives genetic polymorphism of HCC.

Enrollment

1,325 patients

Sex

All

Ages

35 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 35 to 70 years old
  • Compensated cirrhosis or not
  • Caucasian origin of the parents
  • Patient with cirrhosis (histological proof or obvious)

Exclusion criteria

  • HIV, HBV, HCV positive
  • Known Homozygotia (C282Y+/+)
  • Important hepatocytary iron overload for patient with resection
  • HCC non histologically prooved

Trial design

1,325 participants in 2 patient groups

alcoholic cirrhosis with viral infection
Description:
patient with alcoholic cirrhosis with viral infection (300 patients)
Treatment:
Genetic: DNA extraction
alcoholic cirrhosis without viral infection
Description:
patient with alcoholic cirrhosis without viral infection
Treatment:
Genetic: DNA extraction

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems